Meitheal Pharmaceuticals (Meitheal) is pleased to announce the official launch of niCARdipine Hydrochloride Injection, USP:
- 71288-204-11 – niCARdipine Hydrochloride Injection, USP 25mg per 10mL (2.5mg per mL) SDV
ABOUT niCARdipine HYDROCHLORIDE INJECTION, USP
Nicardipine Hydrochloride Injection is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. For prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits.
For full prescribing information, please click on the following link.
Learn more about who we are and what we do at: www.meithealpharma.com.
